Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.
Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.
Generex adds Emmaus CEO to board
Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection
Japan M&A By the Numbers: Q4 2023
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.
Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.